| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3009163 |
| Definition | Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. It is typically used in combination with other drugs to treat parasitic infections, including malaria and toxoplasmosis. When combined with sulfadoxine, it can be used as prophylaxis for Pneumocystis jerovecii (fungi) induced pneumonia (PCP). However, this compound is generally not recommended for PCP prophylaxis unless trimethoprim-sulfamethoxazole, pentamidine, dapsone/pyrimethamine/leucovorin, atovaquone or dapsone cannot be used. |
| SMILES | CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl |
| PubChem | 4993 |
| ChEMBL | CHEMBL36 |
| CHEBI | 8673 |
| CAS | 58-14-0 |
| Drug Class | antibiotic without defined classification |
| Classification | 3 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show |
| Sub-Term(s) | 2 ontology terms | Show + Pneumocystis jerovecii dhfr with mutations associated with resistance to pyrimethamine-sulfadoxine confers_resistance_to_antibiotic + Pneumocystis jerovecii dhfr with mutations associated with resistance to Trimethoprim sulfamethoxazole combined with Pyrimethamine atovaquone confers_resistance_to_antibiotic |
| Publications | EYLES DE, et al. 1955. Antibiot Chemother (Northfield) 5(10):529-39 An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. (PMID 24543765) McFadden DC, et al. 2001. Drug Resist Updat 4(2):79-84 Resistance as a tool in the study of old and new drug targets in Toxoplasma. (PMID 11512524) |
| Curator | Description | Most Recent Edit |
|---|